Processa Pharmaceuticals, Inc. closed fiscal year 2025 with $7.8M in total assets, $2.2M in total liabilities and $5.6M in shareholder equity. Total assets rose 142.0% from the prior fiscal year. The table below carries 10 fiscal years, from 2016 to 2025, and the quarters Processa Pharmaceuticals, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
PCSA Balance Sheet by Fiscal Year
Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $7.8M+142.0% | $3.2M-44.2% | $5.8M-32.9% | $8.6M-67.4% | $26.5M+5.0% | $25.2M+131.7% | $10.9M-12.8% | $12.5M+318.4% | $3.0M+26.1% | $2.4M |
| Total Liabilities | $2.2M+45.9% | $1.5M+92.2% | $797K-30.6% | $1.1M+17.4% | $978K-57.0% | $2.3M-20.8% | $2.9M+3.3% | $2.8M+6.5% | $2.6M+2571.4% | $98K |
| Total Equity | $5.6M+228.8% | $1.7M-66.0% | $5.0M-33.2% | $7.5M-70.7% | $25.5M+11.1% | $22.9M+186.3% | $8.0M-17.4% | $9.7M+2499.7% | $373K-83.5% | $2.3M |
PCSA Balance Sheet by Quarter
Figures are in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'25Filing | Q4'2410-K | Q3'2410-Q | Q2'24Filing | Q1'24Filing | Q4'2310-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $182.0M+2299.8% | $2.1M-74.7% | $4.5M-6.0% | $7.8M+142.0% | $7.6M+53.5% | $8.2M+7.6% | $4.8M-51.6% | $3.2M-44.2% | $4.9M-38.9% | $7.6M-24.7% | $9.9M-20.0% | $5.8M-32.9% |
| Total Liabilities | $363.4M+20653.9% | $2.4M+15.1% | $2.0M+54.3% | $2.2M+45.9% | $1.8M+43.4% | $2.1M+31.5% | $1.3M+20.9% | $1.5M+92.2% | $1.2M+33.5% | $1.6M+69.5% | $1.1M-53.7% | $797K-30.6% |
| Total Equity | -$181.4M-3209.1% | -$318K-105.2% | $2.5M-28.0% | $5.6M+228.8% | $5.8M+56.8% | $6.1M+1.4% | $3.5M-60.3% | $1.7M-66.0% | $3.7M-48.1% | $6.0M-34.2% | $8.9M-12.4% | $5.0M-33.2% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Processa Pharmaceuticals, Inc. financials
Frequently Asked Questions
Processa Pharmaceuticals, Inc. closed fiscal year 2025 with $7.8M in total assets, $2.2M in total liabilities and $5.6M in shareholder equity.
Processa Pharmaceuticals, Inc. (PCSA) total assets rose by 142.0% year over year, from $3.2M to $7.8M in fiscal year 2025.
Across the 10 fiscal years this page covers, Processa Pharmaceuticals, Inc. (PCSA) total assets went from $2.4M in fiscal year 2016 to $7.8M in fiscal year 2025.
Processa Pharmaceuticals, Inc. (PCSA) reported $182.0M in total assets in Q3 2026. This represents an increase of 2299.8% from the same quarter a year earlier.
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Processa Pharmaceuticals, Inc. (PCSA) reported on that line in every period on record.